Cantor Fitzgerald analyst Louise Chen initiated coverage of Innoviva with an Overweight rating. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on INVA: Zai Lab, Innoviva announce China NMPA approval for Xacduro Innoviva Updates Investor Presentation on Website INVA Earnings Report this Week: Is It a Buy, Ahead of Earnings? Innoviva: trial data for uncomplicated gonorrhea treatment presented at ESCMI Disclaimer & DisclosureReport an Issue
